Interim report of the phase III open-label study of Xerecept (corticorelin acetate injection) for treatment of peritumoral brain edema in patients with primary or secondary brain tumors
Mechtler L, Alksne J, Wong E, Arenson E, Recht L, Avgeropolous N, Eisenstat D, Hormigo A, Perry J, Raizer J, Shapiro W, Taylor L, Shulman M, Carr L. Interim report of the phase III open-label study of Xerecept (corticorelin acetate injection) for treatment of peritumoral brain edema in patients with primary or secondary brain tumors. Neuro-Oncology. 2006; 8:446-447.